369648-61-3

Basic information

• Product Name: (S)-ethyl 3-(4-(2,7-naphthyridin-1-ylaMino)phenyl)-2-aMinopropanoate
• Synonyms: (S)-ethyl 3-(4-(2,7-naphthyridin-1-ylaMino)phenyl)-2-aMinopropanoate
• CAS NO: 369648-61-3
• Molecular Formula: C₁₉H₂₀N₄O₂
• Molecular Weight: 336.3877
• Mol File: 369648-61-3.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (S)-ethyl 3-(4-(2,7-naphthyridin-1-ylaMino)phenyl)-2-aMinopropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-ethyl 3-(4-(2,7-naphthyridin-1-ylaMino)phenyl)-2-aMinopropanoate(369648-61-3)
• EPA Substance Registry System: (S)-ethyl 3-(4-(2,7-naphthyridin-1-ylaMino)phenyl)-2-aMinopropanoate(369648-61-3)

Safety Data

• Hazardous Substances Data: 369648-61-3(Hazardous Substances Data)

Usage

Description

(S)-Ethyl 3-(4-(2,7-naphthyridin-1-ylamino)phenyl)-2-aminopropanoate is a complex chemical compound that is an ester derivative of propanoic acid. It features an amino group and a naphthyridine ring, which may contribute to its potential biological activity. The ethyl ester group enhances its solubility in organic solvents, making it a promising candidate for medicinal chemistry and pharmaceutical research.

Uses

Used in Pharmaceutical Research:
(S)-Ethyl 3-(4-(2,7-naphthyridin-1-ylamino)phenyl)-2-aminopropanoate is used as a chemical compound in pharmaceutical research for its potential biological activity. The presence of the naphthyridine ring, which is commonly found in pharmaceutical drugs, suggests that this compound may have applications in the development of new medications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (S)-ethyl 3-(4-(2,7-naphthyridin-1-ylamino)phenyl)-2-aminopropanoate is used as a starting material or intermediate for the synthesis of more complex molecules with potential therapeutic properties. Its unique structure, including the naphthyridine ring and ethyl ester group, may provide a foundation for designing novel drugs with specific targeting or activity profiles.
Used in Drug Formulation:
Due to its increased solubility in organic solvents, (S)-ethyl 3-(4-(2,7-naphthyridin-1-ylamino)phenyl)-2-aminopropanoate can be used as a component in drug formulation. This property may facilitate the development of more effective drug delivery systems, potentially improving the bioavailability and overall efficacy of medications that incorporate this compound.
Used in Chemical Synthesis:
(S)-Ethyl 3-(4-(2,7-naphthyridin-1-ylamino)phenyl)-2-aminopropanoate may also be used as a reactant in chemical synthesis, allowing for the creation of a variety of new compounds with different applications. Its unique structure could be leveraged to produce molecules with specific properties, such as improved stability, selectivity, or potency.

Upstream product

• 369648-62-4 ethyl-(2S)-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]-2-[(t-butoxycarbonyl)amino]propanoate 
• 69042-30-4 1-chloro-[2,7]naphthyridine 
• 67630-01-7 (S)-3-(4-aminophenyl)-2-tert-butoxycarbonylamino-propionic acid ethyl ester 

Downstream Products

• 455264-29-6 UC⁽⁹³³⁾B₁₁₉₄ 

Relevant articles and documents

PHENYLALANINE ENAMIDE DERIVATIVES

Phenylalanine enamide derivatives of formula (1) are described, wherein R1is a -CH(CH3)2, -(CH2)2CH3; -CH2C(CH3)3, -CH2CH2OH, -CH2CH2OCH3, -CH2CH2OCH2CH2OH, -CH2CH2OCH2CH2OCH3, formula (A) group; and the salts, solvates and N-oxides thereof. Compounds according to the invention are potent and selective inhibitors of α4 integrins. The compounds are of use in modulating cell adhesion and in particular are of use in the prophylaxis and treatment of diseases or disorders including inflammation in which the extravasation of leukocytes plays a role and the invention extends to such a use and to the use of the compounds for the manufacture of a medicament for treating such diseases or disorders.